Literature DB >> 26607436

The Relationship Between Serum Endocan Levels With the Presence of Slow Coronary Flow: A Cross-Sectional Study.

Harun Kundi1, Murat Gok1, Emrullah Kiziltunc1, Canan Topcuoglu2, Mustafa Cetin1, Hulya Cicekcioglu1, Burcu Ugurlu1, Feridun Vasfi Ulusoy1.   

Abstract

BACKGROUND: The aim of this study was to investigate the relationship between endocan levels with the presence of slow coronary flow (SCF).
METHODS: In this cross-sectional study, a total of 88 patients, who admitted to our hospital, were included in this study. Of these, 53 patients with SCF and 35 patients with normal coronary flow were included in the final analysis. Coronary flow rates of all patients were determined by the Timi Frame Count (TFC) method.
RESULTS: In correlation analysis, endocan levels revealed a significantly positive correlation with high sensitive C-reactive protein and corrected TFC. In multivariate logistic regression analysis, the endocan levels were found as independently associated with the presence of SCF. Finally, using a cutoff level of 2.3, endocan level predicted the presence of SCF with a sensitivity of 77.2% and specificity of 75.2%.
CONCLUSION: In conclusion, our study showed that higher endocan levels were significantly and independently related to the presence of SCF.

Entities:  

Keywords:  coronary slow flow; endocan level; endothelial dysfunction

Mesh:

Substances:

Year:  2015        PMID: 26607436     DOI: 10.1177/1076029615618024

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  4 in total

1.  The higher serum endocan levels may be a risk factor for the onset of cardiovascular disease: A meta-analysis.

Authors:  Tianming Zhao; Yao Kecheng; Xuelei Zhao; Xuehua Hu; Jing Zhu; Yingnan Wang; Jixiang Ni
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

Review 2.  Endocan: A Key Player of Cardiovascular Disease.

Authors:  Jinzhi Chen; Liping Jiang; Xiao-Hua Yu; Mi Hu; Yang-Kai Zhang; Xin Liu; Pingping He; Xinping Ouyang
Journal:  Front Cardiovasc Med       Date:  2022-01-05

3.  Increased circulating soluble urokinase-type plasminogen activator receptor (suPAR) levels in patients with slow coronary flow.

Authors:  Acar Emrah; İzgi İbrahim Akın; İzci Servet; Kahyaoğlu Muzaffer; Yılmaz Mehmet Fatih; Güler Yeliz; Efe Süleyman Çağan; Güler Ahmet; Kılıçgedik Alev; Kırma Cevat
Journal:  Arch Med Sci Atheroscler Dis       Date:  2016-06-22

4.  Serum markers for asymptomatic atherosclerosis in Egyptian psoriatic patients: study controlled by Doppler estimation of carotid intima-media thickness.

Authors:  Hanan Hassan Sabry; Jehan Hassan Sabry; Aliaa El Husseiny Daifalla; Essam Mohamed Akl; Ahmed Mohamed Hamed; Ahmed Abd Allah Torky
Journal:  Vasc Health Risk Manag       Date:  2018-07-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.